FIRALIS S.A.
Innovative biomarker solutions for improved diagnostics, enhancing patient outcomes and optimizing healthcare costs.
28 employees · est. 2008 · France
SENSEERA
Empowering diagnostics and drug development with AI-driven chromatin liquid biopsy
20 employees · est. 2020 · Jerusalem, Israel
FIRALIS S.A. is the older company (2008 vs 2020).
Side-by-Side Comparison
| Metric | FIRALIS S.A. | SENSEERA |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2020 |
| Headquarters | ||
| Headquarters | France | Jerusalem, Israel |
| Employees | ||
| Employees | 28 | 20 |
| Industry | ||
| Industry | Biotechnology, Health Care, Industrial | Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Not tracked yet |
| Total Funding | ||
| Total Funding | $1.93M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 2 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | AI-driven chromatin liquid biopsy, Diagnostic platform for disease monitoring, Non-invasive gene expression analysis, Biomarker generation for treatment monitoring |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Biotechnology firms, Clinical researchers, Healthcare providers, Diagnostic laboratories |
| Taxonomy | ||
| Taxonomy | Biomarker Development, Diagnostic Tools, Biomarker R&D, Drug Safety, Personalized Medicine, Biomarker-related CRO Services, Proteomics, Genomics, Transcriptomics, Flow Cytometry, Assay Development, Biobanking, Regulatory Qualification, Precision Medicine, Alzheimer's | AI-driven Diagnostics, Chromatin Liquid Biopsy, Biomarker Discovery, Genomic Expression Maps, Cell-free DNA Analysis, Tissue-agnostic MRD Detection, Therapy Response Monitoring, Dose Optimization, Disease Subtyping, Precision Medicine, Drug Development Collaboration, Quantitative Gene Expression, Regulatory Data, Sensitivity And Specificity, Biotech Partnerships |
| Website | ||
| Website | firalis.com | senseerahealth.com |
About FIRALIS S.A.
FIRALIS S.A. is a leading biotechnology company based in Basel, Switzerland, specializing in innovative biomarker solutions for enhanced diagnostics, improved patient outcomes, and optimized healthcare costs. Since its establishment in 2008, the company has been at the forefront of biomarker (BM) di...
About SENSEERA
SENSEERA is a promising player in the Health Care sector, founded in 2020 and based in Israel. The company is pioneering advancements in diagnostics and drug development with its AI-driven chromatin liquid biopsy technology. The foundation of SENSEERA's innovation is its patented GEM (Genomic Expre...
We will tell you when either one moves
BounceWatch watches FIRALIS S.A. and SENSEERA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at FIRALIS S.A. and SENSEERA — by email.
Frequently Asked Questions
Compare FIRALIS S.A. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at FIRALIS S.A. on 7 Jun 2025, and SENSEERA on 5 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.